Resveratrol, Metabolic Syndrome, and Gut Microbiota
AbstractResveratrol is a polyphenol which has been shown to have beneficial effects on metabolic syndrome-related alterations in experimental animals, including glucose and lipid homeostasis improvement and a reduction in fat mass, blood pressure, low-grade inflammation, and oxidative stress. Clinical trials have been carried out to address its potential; however, results are still inconclusive. Even though resveratrol is partly metabolized by gut microbiota, the relevance of this “forgotten organ” had not been widely considered. However, in the past few years, data has emerged suggesting that the therapeutic potential of this compound may be due to its interaction with gut microbiota, reporting changes in bacterial composition associated with beneficial metabolic outcomes. Even though data is still scarce and for the most part observational, it is promising nevertheless, suggesting that resveratrol supplementation could be a useful tool for the treatment of metabolic syndrome and its associated conditions. View Full-Text
Share & Cite This Article
Chaplin, A.; Carpéné, C.; Mercader, J. Resveratrol, Metabolic Syndrome, and Gut Microbiota. Nutrients 2018, 10, 1651.
Chaplin A, Carpéné C, Mercader J. Resveratrol, Metabolic Syndrome, and Gut Microbiota. Nutrients. 2018; 10(11):1651.Chicago/Turabian Style
Chaplin, Alice; Carpéné, Christian; Mercader, Josep. 2018. "Resveratrol, Metabolic Syndrome, and Gut Microbiota." Nutrients 10, no. 11: 1651.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.